CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Evelo Biosciences INC | Stock-Other | 41.21% | — | — | |
| 2 | DNLI | Denali Therapeutics INC | Stock-Other | 26.05% | — | — | |
| 3 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 20.89% | — | — | |
| 4 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 6.27% | — | — | |
| 5 | QTRX | Quanterix CORP | Stock-Other | 5.58% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | QTRX | Quanterix CORP | -4.5% | — | Unchanged |
| 2 | SYRSEUR | Syros Pharmaceuticals INC | -5.8% | — | Unchanged |
| 3 | MCRB1EUR | Seres Therapeutics INC | -6.1% | — | Unchanged |
| 4 | DNLI | Denali Therapeutics INC | -24.9% | — | Unchanged |
| 5 | ✓ | Evelo Biosciences INC | — | NEW | New buy |